Teladoc Health (TDOC) Lifted to “C” at TheStreet

Teladoc Health (NYSE:TDOC) was upgraded by equities research analysts at TheStreet from a “d+” rating to a “c” rating in a note issued to investors on Wednesday.

A number of other research firms have also recently issued reports on TDOC. Zacks Investment Research upgraded shares of Teladoc Health from a “sell” rating to a “hold” rating in a research note on Saturday, January 26th. Cantor Fitzgerald reiterated a “hold” rating and issued a $83.00 target price on shares of Teladoc Health in a research note on Monday, January 7th. Chardan Capital lifted their target price on shares of Teladoc Health from $98.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, November 2nd. Berenberg Bank initiated coverage on shares of Teladoc Health in a research note on Thursday, January 31st. They issued a “buy” rating and a $80.00 target price for the company. Finally, Jefferies Financial Group set a $95.00 target price on shares of Teladoc Health and gave the company a “buy” rating in a research note on Friday, November 2nd. Four research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. Teladoc Health has a consensus rating of “Buy” and a consensus price target of $83.84.

NYSE TDOC opened at $68.25 on Wednesday. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $4.79 billion, a price-to-earnings ratio of -41.36 and a beta of 1.47. Teladoc Health has a 12-month low of $36.60 and a 12-month high of $89.05.

In related news, insider Lewis Levy sold 640 shares of the business’s stock in a transaction on Monday, December 17th. The shares were sold at an average price of $50.00, for a total transaction of $32,000.00. Following the transaction, the insider now owns 640 shares of the company’s stock, valued at $32,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason N. Gorevic sold 30,000 shares of the business’s stock in a transaction on Wednesday, December 19th. The shares were sold at an average price of $49.55, for a total transaction of $1,486,500.00. Following the completion of the sale, the chief executive officer now directly owns 536,184 shares in the company, valued at approximately $26,567,917.20. The disclosure for this sale can be found here. Insiders sold 130,745 shares of company stock valued at $7,911,090 over the last 90 days. 3.95% of the stock is owned by corporate insiders.

Institutional investors have recently made changes to their positions in the business. California Public Employees Retirement System acquired a new position in Teladoc Health during the 2nd quarter worth about $203,000. Bank of Montreal Can lifted its position in Teladoc Health by 41.4% during the 3rd quarter. Bank of Montreal Can now owns 20,565 shares of the health services provider’s stock worth $1,776,000 after buying an additional 6,019 shares in the last quarter. Retirement Systems of Alabama acquired a new position in Teladoc Health during the 3rd quarter worth about $3,471,000. First Trust Advisors LP lifted its position in Teladoc Health by 7.8% during the 3rd quarter. First Trust Advisors LP now owns 168,535 shares of the health services provider’s stock worth $14,553,000 after buying an additional 12,257 shares in the last quarter. Finally, BKS Advisors LLC acquired a new position in Teladoc Health during the 3rd quarter worth about $1,203,000.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: How analysts view the yield curve

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit